
|Videos|September 28, 2022
- MHE September 2022
- Volume 32
- Issue 9
Bringing Out the Leader in Those Aspiring is Something Mairéad McInerney of AmeriHealth Caritas is Proud of in Her Career
Author(s)Peter Wehrwein
McInerney, corporate director of population health and wellness coordination at AmeriHealth Caritas, headquartered in Philadelphia, is one of 10 winners in this year's Emerging Industry Leaders series.
Advertisement
Mairéad McInerney, M.S.W., LCSW, CCM, corporate director of population health, wellness coordination, at AmeriHealth Caritas, headquartered in Philadelphia, is one of the 10 up-and-coming healthcare leaders featured in the annual Managed Healthcare Executive feature. In this video she talks about the career achievement that she is most proud of, what she would change in U.S. healthcare and how she avoids burnout.
Articles in this issue
about 4 years ago
Emerging Industry Leaders: Joyce Chan Russell of Priority Healthabout 4 years ago
Emerging Industry Leaders: Mairéad McInerney of AmeriHealth CaritasAdvertisement
Related to this article

Findings from an analysis of IQVIA claims data show a prevalence rate that is five times lower than previous reports. Some of the discrepancy could be chalked up to the difference between using claims data instead of self-reporting by survey respondents.

Epic Research finds over half of children with type 1 diabetes miss autoantibody testing, risking misdiagnosis and limiting early treatment options like Tzield.

Higher MRI-measured liver disease activity was linked to lower quality of life and more anxiety and activity problems in 802 adults with suspected MASLD/MASH in Europe.

Teen boys with obesity and lower baseline fitness were less likely to see MASLD resolve during a lifestyle program, a Belgian study found.

MassHealth's Katelyn Meyer, Pharm.D., says mandatory coverage, young patients and an unpredictable FDA make planning for new specialty drugs a challenge.

A truly transparent PBM arrangement starts with full disclosure of direct and indirect compensation.

The rule requires pharmacy benefit managers to disclose rebates and discounts, money made from spread pricing and incentives for formulary placement.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Liver MRI marker tied to lower quality of life in MASH, trial finds
2
The ripple effects of Medicare’s maximum fair price with Hiva Pourarsalan, Pharm.D. | AMCP Nexus 2026
3
Fewer than half of newly diagnosed children with type 1 diabetes get autoantibody testing
4
Medicaid can't opt out of gene therapies, so planning matters more, says Katelyn Meyer, Pharm.D. | AMCP Nexus 2026
5

